Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 3/2019

17.02.2018 | Case Report

Inflammatory Myofibroblastic Tumor of the Mid Common Bile Duct Masquerading as Cholangiocarcinoma

verfasst von: Ritu Verma, Arpita Saha, Kaushik Saha

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Excerpt

Inflammatory myofibroblastic tumors (IMTs) of the biliary ducts represent an uncommon cause of obstructive jaundice. It mimics cholangiocarcinoma both clinically and radiologically. Only nine reports of the biliary IMT have been reported in the literature [1]. Here, we report a case of biliary IMT presenting with recurrent episodes of obstructive jaundice. …
Literatur
1.
Zurück zum Zitat Vasiliadis K, Fortounis K, Papavasiliou C, Kokarhidas A, Fachiridis D, et al. Mid common bile duct inflammatory pseudotumor mimicking cholangiocarcinoma. A case report and literature review. Int J Surg Case Rep. 2014;5:12–5.CrossRefPubMed Vasiliadis K, Fortounis K, Papavasiliou C, Kokarhidas A, Fachiridis D, et al. Mid common bile duct inflammatory pseudotumor mimicking cholangiocarcinoma. A case report and literature review. Int J Surg Case Rep. 2014;5:12–5.CrossRefPubMed
2.
Zurück zum Zitat Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumor. In: Fletcher CDM, Bridge JA, Hogendooorn PCW, Mertern F, editors. WHO classification of tumors of soft tissue and bone. 4th edition. IARC. Lyon; 2013. Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumor. In: Fletcher CDM, Bridge JA, Hogendooorn PCW, Mertern F, editors. WHO classification of tumors of soft tissue and bone. 4th edition. IARC. Lyon; 2013.
3.
Zurück zum Zitat Tublin ME, Moser AJ, Marsh JW, Gamblin TC. Biliary inflammatory pseudotumor: imaging features in seven patients. Am J Roentegenol. 2007;188:44–8.CrossRef Tublin ME, Moser AJ, Marsh JW, Gamblin TC. Biliary inflammatory pseudotumor: imaging features in seven patients. Am J Roentegenol. 2007;188:44–8.CrossRef
4.
Zurück zum Zitat Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19:859–72.CrossRefPubMed Coffin CM, Watterson J, Priest JR, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases. Am J Surg Pathol. 1995;19:859–72.CrossRefPubMed
5.
Zurück zum Zitat Hakozaki Y, Katou M, Nakagawa K, Shirahama T, Matsumoto T. Improvement of inflammatory pseudotumor of the liver after nonsteroidal anti-inflammatory agent therapy. Am J Gastroenterol. 1993;88:1121–2.PubMed Hakozaki Y, Katou M, Nakagawa K, Shirahama T, Matsumoto T. Improvement of inflammatory pseudotumor of the liver after nonsteroidal anti-inflammatory agent therapy. Am J Gastroenterol. 1993;88:1121–2.PubMed
6.
Zurück zum Zitat Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000;60:1306–1311. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000;60:1306–1311.
7.
Zurück zum Zitat Diop B, Konate I, Ka S, Sall I, Fall D, Dieng M, et al. Mesentric myofibroblastic tumor: NSAID therapy after incomplete resection. J Visc Surg. 2011;148:e311–4.CrossRefPubMed Diop B, Konate I, Ka S, Sall I, Fall D, Dieng M, et al. Mesentric myofibroblastic tumor: NSAID therapy after incomplete resection. J Visc Surg. 2011;148:e311–4.CrossRefPubMed
8.
Zurück zum Zitat Difiore JW, Goldblum JR. Inflammatory myofibroblastic tumor of the small intestine. J Am Coll Surg. 2002;294:502–6.CrossRef Difiore JW, Goldblum JR. Inflammatory myofibroblastic tumor of the small intestine. J Am Coll Surg. 2002;294:502–6.CrossRef
9.
Zurück zum Zitat Meis JM, Enzinger FM. Inflammatory fibrosarcoma of the mesentry and retroperitoneum. A tumor closely simulating inflammatory pseudotumor. Am J Surg Pathol. 1991;15:1146–56.CrossRefPubMed Meis JM, Enzinger FM. Inflammatory fibrosarcoma of the mesentry and retroperitoneum. A tumor closely simulating inflammatory pseudotumor. Am J Surg Pathol. 1991;15:1146–56.CrossRefPubMed
10.
Zurück zum Zitat Donner LR, Trompler RA, White RR 4th. Progression of inflammatory myofibroblastic tumor (inflammatory pseudotumor) of soft tissue into sarcoma after several recurrences. Hum Pathol 1996;27:1095–1098. Donner LR, Trompler RA, White RR 4th. Progression of inflammatory myofibroblastic tumor (inflammatory pseudotumor) of soft tissue into sarcoma after several recurrences. Hum Pathol 1996;27:1095–1098.
11.
Zurück zum Zitat Gale N, Zidar N, Podboj J, Volvsek M, Luzar B. Inflammatory myofibroblastic tumor of paranasal sinuses with fatal outcome: reactive lesion or tumor. J Clin Pathol. 2003;56:715–7.CrossRefPubMedCentralPubMed Gale N, Zidar N, Podboj J, Volvsek M, Luzar B. Inflammatory myofibroblastic tumor of paranasal sinuses with fatal outcome: reactive lesion or tumor. J Clin Pathol. 2003;56:715–7.CrossRefPubMedCentralPubMed
12.
Zurück zum Zitat Hussong JW, Brown M, Perkins SL, Dehner LP, Coffin CM. Comparison of DNA ploidy, histologic and immunohistochemical findings with clinical outcome inflammatory myofibroblastic tumors. Mod Pathol. 1999;12:279–86.PubMed Hussong JW, Brown M, Perkins SL, Dehner LP, Coffin CM. Comparison of DNA ploidy, histologic and immunohistochemical findings with clinical outcome inflammatory myofibroblastic tumors. Mod Pathol. 1999;12:279–86.PubMed
Metadaten
Titel
Inflammatory Myofibroblastic Tumor of the Mid Common Bile Duct Masquerading as Cholangiocarcinoma
verfasst von
Ritu Verma
Arpita Saha
Kaushik Saha
Publikationsdatum
17.02.2018
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 3/2019
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-018-0074-7

Weitere Artikel der Ausgabe 3/2019

Journal of Gastrointestinal Cancer 3/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.